AlphaGrep UK Ltd’s Idexx Laboratories IDXX Stock Holding History

AlphaGrep UK Ltd’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$534K	Buy	950 +475	+100%	+$305K	0.15%	217
2025 Q4	$321K	Buy	+475	New	+$323K	0.11%	386

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK Ltd's IDXX Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Idexx Laboratories (IDXX) stake by 100% in Q1 2026, buying an estimated $305K and bringing the position to 950 shares worth $534K. The position accounts for 0.15% of the portfolio, ranked #217.

AlphaGrep UK Ltd first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

AlphaGrep UK Ltd held 950 shares of Idexx Laboratories worth $534K as of Q1 2026.
AlphaGrep UK Ltd bought 475 Idexx Laboratories shares in Q1 2026, an estimated $305K.
Idexx Laboratories made up 0.15% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #217 holding.
AlphaGrep UK Ltd first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.